To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

Constellation Pharma teams up with Genentech

By Chris Reidy

 |  Globe Staff  

  January 17, 2012

Constellation Pharmaceuticals Inc. said that it has entered into a major strategic agreement with Genentech, a California-based member of the Roche Group, to launch a broad collaboration based on the science of epigenetics and chromatin biology to discover and develop treatments for cancer and other serious diseases. Under the agreement, Cambridge-based Constellation said it will receive committed funding of $95 million. Genentech has a future option to acquire all outstanding shares of Constellation based on pre-negotiated terms.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help